Retapamulin
id:
retapamulin-321-5422158
title:
Retapamulin
text:
Retapamulin is a topical antibiotic developed by GlaxoSmithKline. It is the first drug in the new class of pleuromutilin antibiotics to be approved for human use. It is marketed as an ointment under the brand names Altabax and Altargo. Retapamulin was approved by the United States Food and Drug Administration in April 2007 for the treatment of bacterial skin infections such as impetigo. In May 2007, retapamulin received approval in the EU from the European Medicines Agency for the same indicatio
brand slug:
wiki
category slug:
encyclopedia
description:
Pharmaceutical drug
original url:
https://en.wikipedia.org/wiki/Retapamulin
date created:
date modified:
2023-12-20T21:41:07Z
main entity:
{"identifier":"Q7316645","url":"https://www.wikidata.org/entity/Q7316645"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/e/e3/Retapamulin.svg","width":1753,"height":1081}
fields total:
13
integrity:
15